Effect of short-chain carbohydrates on human intestinal bifidobacteria and Escherichia coli in vitro

School of Applied Sciences, South Bank University, 103 Borough Road, London SE1 0AA, *Department of Civil Engineering, Technological Institute, Northwestern University, Evanston IL 60201, USA and MRC Microbiology and Gut Biology Group, Level 6, Ninewells Hospital and Medical School, Dundee DD1 9SY C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical microbiology 2001-02, Vol.50 (2), p.152-160
Hauptverfasser: SHARP, R, FISHBAIN, S, MACFARLANE, G.T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 160
container_issue 2
container_start_page 152
container_title Journal of medical microbiology
container_volume 50
creator SHARP, R
FISHBAIN, S
MACFARLANE, G.T
description School of Applied Sciences, South Bank University, 103 Borough Road, London SE1 0AA, *Department of Civil Engineering, Technological Institute, Northwestern University, Evanston IL 60201, USA and MRC Microbiology and Gut Biology Group, Level 6, Ninewells Hospital and Medical School, Dundee DD1 9SY Corresponding author: Dr R. Sharp (e-mail: sharp{at}sbu.ac.uk ). Received 17 Jan. 2000; revised version received 19 June 2000; accepted 20 June 2000. Abstract Plate counts and small subunit (SSU) rRNA abundance were used to study the effects of fructo-oligosaccharides (FOS), fructose, or galacto-oligosaccharides (GOS) on bifidobacterial populations in human faecal microbiotas. The bacteria were grown in pH-controlled anaerobic fermentation vessels. Untreated cultures and fructose-amended fermenters were used as controls. Bifidobacterium longum , B. adolescentis and B. angulatum comprised the dominant bifidobacterial populations throughout the experiment. No major differences were found in the four treatments, in terms of viable counts of the organisms or of total populations of bifidobacteria at any time point. However, large differences were observed with respect to the abundance of bifidobacterial SSU rRNA between the treatments. Greatest bifidobacterial SSU rRNA abundance was seen in FOS cultures, with the lowest in the untreated control fermentation. GOS and fructose also increased bifidobacterial SSU rRNA. Cultures supplemented with FOS and GOS were also associated with lower colony counts and SSU rRNA abundance for Escherichia coli , compared with fructose-supplemented and control fermenters. At the 24-h time point, the untreated control contained 19.8 µg of enterobacterial SSU rRNA/ml of culture fluid, compared with 11.4 µg/ml for the fructose fermentation, and 2.6 and 0.5 µg/ml for the FOS and GOS culture vessels, respectively.
doi_str_mv 10.1099/0022-1317-50-2-152
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70588918</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70588918</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-4a67501d4efc4f7f574a0cd2022606a86179d3b079461725d87f66983d757ac03</originalsourceid><addsrcrecordid>eNqFkU1vFDEMhiMEotuWP8AB5QI9DU0y-ZpjVS0UqRIXOEeefHRSzSQlmW3Vf0-WXdFjJUt-X-mx49gIfaTkKyXDcEkIYx3tqeoE6ZoS7A3aUK76TkjO36LNP4BJKk7Qaa33hFDV98N7dEIpa8HYBrltCN6uOAdcp1zWzk4QE7ZQxjw9uwKrrzgnPO0WSDimZteYYMZjDNHlEezqSwQMyeFttVMzdmre5jk2HD_GteRz9C7AXP2HYz5Dv79tf13fdLc_v_-4vrrtLO_l2nGQShDquA-WBxWE4kCsY-0XkkjQkqrB9SNRA2-SCadVkHLQvVNCgSX9Gfpy6PtQ8p9dm9QssVo_z5B83lWjiNB6oPpVkCpNtCCigewA2pJrLT6YhxIXKM-GErM_gtnv2OyPYAQxTQnWij4du-_GxbuXkuPWG_D5CEC1MIcCycb6wnEqmeZD4y4O3BTvpqdYvLnzaYltljFmc78s_5_8C2VCnA4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17808505</pqid></control><display><type>article</type><title>Effect of short-chain carbohydrates on human intestinal bifidobacteria and Escherichia coli in vitro</title><source>MEDLINE</source><source>Microbiology Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>SHARP, R ; FISHBAIN, S ; MACFARLANE, G.T</creator><creatorcontrib>SHARP, R ; FISHBAIN, S ; MACFARLANE, G.T</creatorcontrib><description>School of Applied Sciences, South Bank University, 103 Borough Road, London SE1 0AA, *Department of Civil Engineering, Technological Institute, Northwestern University, Evanston IL 60201, USA and MRC Microbiology and Gut Biology Group, Level 6, Ninewells Hospital and Medical School, Dundee DD1 9SY Corresponding author: Dr R. Sharp (e-mail: sharp{at}sbu.ac.uk ). Received 17 Jan. 2000; revised version received 19 June 2000; accepted 20 June 2000. Abstract Plate counts and small subunit (SSU) rRNA abundance were used to study the effects of fructo-oligosaccharides (FOS), fructose, or galacto-oligosaccharides (GOS) on bifidobacterial populations in human faecal microbiotas. The bacteria were grown in pH-controlled anaerobic fermentation vessels. Untreated cultures and fructose-amended fermenters were used as controls. Bifidobacterium longum , B. adolescentis and B. angulatum comprised the dominant bifidobacterial populations throughout the experiment. No major differences were found in the four treatments, in terms of viable counts of the organisms or of total populations of bifidobacteria at any time point. However, large differences were observed with respect to the abundance of bifidobacterial SSU rRNA between the treatments. Greatest bifidobacterial SSU rRNA abundance was seen in FOS cultures, with the lowest in the untreated control fermentation. GOS and fructose also increased bifidobacterial SSU rRNA. Cultures supplemented with FOS and GOS were also associated with lower colony counts and SSU rRNA abundance for Escherichia coli , compared with fructose-supplemented and control fermenters. At the 24-h time point, the untreated control contained 19.8 µg of enterobacterial SSU rRNA/ml of culture fluid, compared with 11.4 µg/ml for the fructose fermentation, and 2.6 and 0.5 µg/ml for the FOS and GOS culture vessels, respectively.</description><identifier>ISSN: 0022-2615</identifier><identifier>EISSN: 1473-5644</identifier><identifier>DOI: 10.1099/0022-1317-50-2-152</identifier><identifier>PMID: 11211222</identifier><identifier>CODEN: JMMIAV</identifier><language>eng</language><publisher>Reading: Soc General Microbiol</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal agents ; Bacteriology ; Bifidobacterium ; Bifidobacterium - chemistry ; Bifidobacterium - drug effects ; Bifidobacterium - growth &amp; development ; Biological and medical sciences ; Colony Count, Microbial ; Culture Media ; Escherichia coli ; Escherichia coli - chemistry ; Escherichia coli - drug effects ; Escherichia coli - growth &amp; development ; Fatty Acids - analysis ; Fermentation ; Fundamental and applied biological sciences. Psychology ; Humans ; Intestine, Large - microbiology ; Medical sciences ; Microbiology ; Nucleic Acid Hybridization - methods ; Oligonucleotide Probes ; Oligosaccharides - pharmacology ; Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains ; Pharmacology. Drug treatments ; RNA, Ribosomal - analysis</subject><ispartof>Journal of medical microbiology, 2001-02, Vol.50 (2), p.152-160</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-4a67501d4efc4f7f574a0cd2022606a86179d3b079461725d87f66983d757ac03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3746,3747,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14162849$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11211222$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SHARP, R</creatorcontrib><creatorcontrib>FISHBAIN, S</creatorcontrib><creatorcontrib>MACFARLANE, G.T</creatorcontrib><title>Effect of short-chain carbohydrates on human intestinal bifidobacteria and Escherichia coli in vitro</title><title>Journal of medical microbiology</title><addtitle>J Med Microbiol</addtitle><description>School of Applied Sciences, South Bank University, 103 Borough Road, London SE1 0AA, *Department of Civil Engineering, Technological Institute, Northwestern University, Evanston IL 60201, USA and MRC Microbiology and Gut Biology Group, Level 6, Ninewells Hospital and Medical School, Dundee DD1 9SY Corresponding author: Dr R. Sharp (e-mail: sharp{at}sbu.ac.uk ). Received 17 Jan. 2000; revised version received 19 June 2000; accepted 20 June 2000. Abstract Plate counts and small subunit (SSU) rRNA abundance were used to study the effects of fructo-oligosaccharides (FOS), fructose, or galacto-oligosaccharides (GOS) on bifidobacterial populations in human faecal microbiotas. The bacteria were grown in pH-controlled anaerobic fermentation vessels. Untreated cultures and fructose-amended fermenters were used as controls. Bifidobacterium longum , B. adolescentis and B. angulatum comprised the dominant bifidobacterial populations throughout the experiment. No major differences were found in the four treatments, in terms of viable counts of the organisms or of total populations of bifidobacteria at any time point. However, large differences were observed with respect to the abundance of bifidobacterial SSU rRNA between the treatments. Greatest bifidobacterial SSU rRNA abundance was seen in FOS cultures, with the lowest in the untreated control fermentation. GOS and fructose also increased bifidobacterial SSU rRNA. Cultures supplemented with FOS and GOS were also associated with lower colony counts and SSU rRNA abundance for Escherichia coli , compared with fructose-supplemented and control fermenters. At the 24-h time point, the untreated control contained 19.8 µg of enterobacterial SSU rRNA/ml of culture fluid, compared with 11.4 µg/ml for the fructose fermentation, and 2.6 and 0.5 µg/ml for the FOS and GOS culture vessels, respectively.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal agents</subject><subject>Bacteriology</subject><subject>Bifidobacterium</subject><subject>Bifidobacterium - chemistry</subject><subject>Bifidobacterium - drug effects</subject><subject>Bifidobacterium - growth &amp; development</subject><subject>Biological and medical sciences</subject><subject>Colony Count, Microbial</subject><subject>Culture Media</subject><subject>Escherichia coli</subject><subject>Escherichia coli - chemistry</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - growth &amp; development</subject><subject>Fatty Acids - analysis</subject><subject>Fermentation</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Intestine, Large - microbiology</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Nucleic Acid Hybridization - methods</subject><subject>Oligonucleotide Probes</subject><subject>Oligosaccharides - pharmacology</subject><subject>Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains</subject><subject>Pharmacology. Drug treatments</subject><subject>RNA, Ribosomal - analysis</subject><issn>0022-2615</issn><issn>1473-5644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1vFDEMhiMEotuWP8AB5QI9DU0y-ZpjVS0UqRIXOEeefHRSzSQlmW3Vf0-WXdFjJUt-X-mx49gIfaTkKyXDcEkIYx3tqeoE6ZoS7A3aUK76TkjO36LNP4BJKk7Qaa33hFDV98N7dEIpa8HYBrltCN6uOAdcp1zWzk4QE7ZQxjw9uwKrrzgnPO0WSDimZteYYMZjDNHlEezqSwQMyeFttVMzdmre5jk2HD_GteRz9C7AXP2HYz5Dv79tf13fdLc_v_-4vrrtLO_l2nGQShDquA-WBxWE4kCsY-0XkkjQkqrB9SNRA2-SCadVkHLQvVNCgSX9Gfpy6PtQ8p9dm9QssVo_z5B83lWjiNB6oPpVkCpNtCCigewA2pJrLT6YhxIXKM-GErM_gtnv2OyPYAQxTQnWij4du-_GxbuXkuPWG_D5CEC1MIcCycb6wnEqmeZD4y4O3BTvpqdYvLnzaYltljFmc78s_5_8C2VCnA4</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>SHARP, R</creator><creator>FISHBAIN, S</creator><creator>MACFARLANE, G.T</creator><general>Soc General Microbiol</general><general>Society for General Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20010201</creationdate><title>Effect of short-chain carbohydrates on human intestinal bifidobacteria and Escherichia coli in vitro</title><author>SHARP, R ; FISHBAIN, S ; MACFARLANE, G.T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-4a67501d4efc4f7f574a0cd2022606a86179d3b079461725d87f66983d757ac03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal agents</topic><topic>Bacteriology</topic><topic>Bifidobacterium</topic><topic>Bifidobacterium - chemistry</topic><topic>Bifidobacterium - drug effects</topic><topic>Bifidobacterium - growth &amp; development</topic><topic>Biological and medical sciences</topic><topic>Colony Count, Microbial</topic><topic>Culture Media</topic><topic>Escherichia coli</topic><topic>Escherichia coli - chemistry</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - growth &amp; development</topic><topic>Fatty Acids - analysis</topic><topic>Fermentation</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Intestine, Large - microbiology</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Nucleic Acid Hybridization - methods</topic><topic>Oligonucleotide Probes</topic><topic>Oligosaccharides - pharmacology</topic><topic>Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains</topic><topic>Pharmacology. Drug treatments</topic><topic>RNA, Ribosomal - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SHARP, R</creatorcontrib><creatorcontrib>FISHBAIN, S</creatorcontrib><creatorcontrib>MACFARLANE, G.T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SHARP, R</au><au>FISHBAIN, S</au><au>MACFARLANE, G.T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of short-chain carbohydrates on human intestinal bifidobacteria and Escherichia coli in vitro</atitle><jtitle>Journal of medical microbiology</jtitle><addtitle>J Med Microbiol</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>50</volume><issue>2</issue><spage>152</spage><epage>160</epage><pages>152-160</pages><issn>0022-2615</issn><eissn>1473-5644</eissn><coden>JMMIAV</coden><abstract>School of Applied Sciences, South Bank University, 103 Borough Road, London SE1 0AA, *Department of Civil Engineering, Technological Institute, Northwestern University, Evanston IL 60201, USA and MRC Microbiology and Gut Biology Group, Level 6, Ninewells Hospital and Medical School, Dundee DD1 9SY Corresponding author: Dr R. Sharp (e-mail: sharp{at}sbu.ac.uk ). Received 17 Jan. 2000; revised version received 19 June 2000; accepted 20 June 2000. Abstract Plate counts and small subunit (SSU) rRNA abundance were used to study the effects of fructo-oligosaccharides (FOS), fructose, or galacto-oligosaccharides (GOS) on bifidobacterial populations in human faecal microbiotas. The bacteria were grown in pH-controlled anaerobic fermentation vessels. Untreated cultures and fructose-amended fermenters were used as controls. Bifidobacterium longum , B. adolescentis and B. angulatum comprised the dominant bifidobacterial populations throughout the experiment. No major differences were found in the four treatments, in terms of viable counts of the organisms or of total populations of bifidobacteria at any time point. However, large differences were observed with respect to the abundance of bifidobacterial SSU rRNA between the treatments. Greatest bifidobacterial SSU rRNA abundance was seen in FOS cultures, with the lowest in the untreated control fermentation. GOS and fructose also increased bifidobacterial SSU rRNA. Cultures supplemented with FOS and GOS were also associated with lower colony counts and SSU rRNA abundance for Escherichia coli , compared with fructose-supplemented and control fermenters. At the 24-h time point, the untreated control contained 19.8 µg of enterobacterial SSU rRNA/ml of culture fluid, compared with 11.4 µg/ml for the fructose fermentation, and 2.6 and 0.5 µg/ml for the FOS and GOS culture vessels, respectively.</abstract><cop>Reading</cop><pub>Soc General Microbiol</pub><pmid>11211222</pmid><doi>10.1099/0022-1317-50-2-152</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2615
ispartof Journal of medical microbiology, 2001-02, Vol.50 (2), p.152-160
issn 0022-2615
1473-5644
language eng
recordid cdi_proquest_miscellaneous_70588918
source MEDLINE; Microbiology Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal agents
Bacteriology
Bifidobacterium
Bifidobacterium - chemistry
Bifidobacterium - drug effects
Bifidobacterium - growth & development
Biological and medical sciences
Colony Count, Microbial
Culture Media
Escherichia coli
Escherichia coli - chemistry
Escherichia coli - drug effects
Escherichia coli - growth & development
Fatty Acids - analysis
Fermentation
Fundamental and applied biological sciences. Psychology
Humans
Intestine, Large - microbiology
Medical sciences
Microbiology
Nucleic Acid Hybridization - methods
Oligonucleotide Probes
Oligosaccharides - pharmacology
Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains
Pharmacology. Drug treatments
RNA, Ribosomal - analysis
title Effect of short-chain carbohydrates on human intestinal bifidobacteria and Escherichia coli in vitro
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T18%3A33%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20short-chain%20carbohydrates%20on%20human%20intestinal%20bifidobacteria%20and%20Escherichia%20coli%20in%20vitro&rft.jtitle=Journal%20of%20medical%20microbiology&rft.au=SHARP,%20R&rft.date=2001-02-01&rft.volume=50&rft.issue=2&rft.spage=152&rft.epage=160&rft.pages=152-160&rft.issn=0022-2615&rft.eissn=1473-5644&rft.coden=JMMIAV&rft_id=info:doi/10.1099/0022-1317-50-2-152&rft_dat=%3Cproquest_cross%3E70588918%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17808505&rft_id=info:pmid/11211222&rfr_iscdi=true